• Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
Search
FDAReview.org
  • Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About

Raymond March

25 POSTS 0 COMMENTS
Raymond J. March is a Research Fellow at the Independent Institute and Assistant Professor of Economics at North Dakota State University.
All Blog Posts | Full bio and publications

Misdiagnosing Right-to-try Laws

Raymond March - July 6, 2018
0

Putting Right-to-Try Drug Prices in Perspective

Raymond March - July 2, 2018
0

EpiPen Pricing Controversy Reveals Ignorance about Market Competition

Raymond March - June 22, 2018
0

FDA Moves Closer to Approving Ecstasy

Raymond March - June 19, 2018
0

Right-to-Try Law Signed!

Raymond March - June 18, 2018
0

Curing Diseases Is Sustainable, Government in Healthcare Is Not

Raymond March - May 3, 2018
0

FDA Issues First Mandatory Recall for Contaminated Food

Raymond March - April 25, 2018
0

FDA Restricts Sale of Contraceptive Device

Raymond March - April 18, 2018
0

FDA Cracks Down on Online Eye-Exam Company

Raymond March - April 5, 2018
0

The FDA Plans to Regulate Nicotine in Cigarettes

Raymond March - April 3, 2018
0
123Page 2 of 3
© 2018 Independent Institute, 100 Swan Way, Oakland CA 94621-1428 | (510) 632‑1366.
Edit with Live CSS
Save
Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.